Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ghrelin in Anterior Circulation Ischemic Stroke Treated With EVT
NCT05726240Phase 2Unknown
- Sponsor
- Rijnstate
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human ghrelin in ischemic stroke, sponsored by Rijnstate. Status: unknown.
02
Drugs
human ghrelin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05726240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05726240.